INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 224 filers reported holding INSMED INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $45,237,395 | +162.5% | 675,185 | +6.3% | 0.77% | +186.7% |
Q1 2024 | $17,232,569 | -12.5% | 635,185 | 0.0% | 0.27% | -15.9% |
Q4 2023 | $19,684,383 | +22.7% | 635,185 | 0.0% | 0.32% | +11.5% |
Q3 2023 | $16,038,421 | -16.7% | 635,185 | -30.4% | 0.29% | -11.4% |
Q2 2023 | $19,245,373 | +23.8% | 912,103 | 0.0% | 0.32% | +14.0% |
Q1 2023 | $15,551,356 | +11.4% | 912,103 | +30.6% | 0.28% | +3.6% |
Q4 2022 | $13,954,292 | +424.4% | 698,413 | +232.6% | 0.28% | +84.6% |
Q1 2016 | $2,661,000 | -30.2% | 210,000 | 0.0% | 0.15% | -22.0% |
Q4 2015 | $3,812,000 | +42.0% | 210,000 | +45.2% | 0.19% | +22.4% |
Q3 2015 | $2,685,000 | +24.1% | 144,600 | +63.2% | 0.16% | +33.3% |
Q2 2015 | $2,164,000 | +17.4% | 88,600 | 0.0% | 0.12% | -15.8% |
Q1 2015 | $1,843,000 | +34.4% | 88,600 | 0.0% | 0.14% | -7.3% |
Q4 2014 | $1,371,000 | +18.6% | 88,600 | 0.0% | 0.15% | -6.8% |
Q3 2014 | $1,156,000 | -34.7% | 88,600 | 0.0% | 0.16% | -33.2% |
Q2 2014 | $1,770,000 | +29.1% | 88,600 | +23.1% | 0.24% | +13.1% |
Q1 2014 | $1,371,000 | +144.8% | 72,000 | +118.8% | 0.21% | +23.1% |
Q4 2013 | $560,000 | – | 32,900 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |